Furthermore, RASGRP2, one of the novel autoantigens is upregulated in proinflammatory B cells in MS and can be cross-recognized by autoreactive T cells that also respond to EBV- and Akkermansia-derived peptides (26). This evidence concerns the gene RASGRP2 and myeloid sarcoma.